Scribe Therapeutics Inc.'s next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
As of June 30, 2026, Scribe Therapeutics Inc. has 17.58M shares outstanding.
| Shares Outstanding | 17.58M |
As of June 30, 2026, Scribe Therapeutics Inc. maintains a current ratio of 0.57, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -26.25, indicating conservative leverage, while an interest coverage ratio of -31.20 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.57 |
| Quick Ratio | 0.56 |
| Debt / Equity | -26.25 |
| Interest Coverage | -31.20 |
These figures cover the twelve months ended June 30, 2026. The company generates approximately 19,571.43 in revenue per employee across its workforce of 98.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 19,571.43 |
| Employee Count | 98.00 |
Over the twelve months ended June 30, 2026, Scribe Therapeutics Inc. recorded 212,000.00 in income tax expense.
| Income Tax | 212,000.00 |
These figures are as of the close on November 16, 2026.
| 50-Day Moving Average | 20.86 |
These figures cover the twelve months ended June 30, 2026.
| Pretax Income | -6.26M |
As of June 30, 2026, Scribe Therapeutics Inc. holds 43.01M in cash and equivalents against 43.27M in total debt, resulting in a net debt position of 2.21M. Total book value stands at -164.85M, with working capital of -33.59M providing operational flexibility.
| Cash & Cash Equivalents | 43.01M |
| Total Debt | 43.27M |
| Net Debt | 2.21M |
| Equity (Book Value) | -164.85M |
| Book Value Per Share | -9.38 |
| Working Capital | -33.59M |
These figures cover the twelve months ended June 30, 2026. After subtracting -10,000.00 in capital expenditures, free cash flow totaled -5.35M - equivalent to -0.33 per share.
| Capital Expenditures | -10,000.00 |
| Free Cash Flow | -5.35M |
| FCF Per Share | -0.33 |
These figures cover the twelve months ended June 30, 2026. The operating margin of -489.83 and net profit margin of -337.70 provide insight into operational efficiency.
| Operating Margin | -489.83 |
| Pretax Margin | -326.64 |
| Profit Margin | -337.70 |